Date published: 2026-4-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

MOB1A Activators

MOB1A, short for MOB Kinase Activator 1A, is a crucial component in cellular biology, particularly in the Hippo signaling pathway. This pathway is a key regulator of organ size and tissue homeostasis by controlling cell proliferation, apoptosis (programmed cell death), and stem cell renewal. MOB1A, along with its closely related paralog MOB1B, is involved in the regulation and execution of these processes.The MOB1A protein acts as a core component and a facilitator in the Hippo pathway. It interacts with and activates key kinases in the pathway, such as LATS1/2 (large tumor suppressor kinases). This activation leads to the phosphorylation and subsequent inactivation of YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif), which are transcription co-activators involved in cell growth and survival. By inhibiting YAP and TAZ, MOB1A plays a crucial role in controlling cell proliferation and apoptosis.

The importance of MOB1A is highlighted in its role in tumor suppression. Dysregulation of the Hippo pathway, and by extension MOB1A, has been implicated in the development of various cancers. The loss or mutation of MOB1A can lead to uncontrolled cell growth and tumor formation due to the unchecked activity of YAP and TAZ.Furthermore, MOB1A has been studied in the context of other cellular processes, including cell polarity, migration, and differentiation. Its involvement in these diverse processes underscores its significance in maintaining cellular and tissue homeostasis.In summary, MOB1A is a vital player in the Hippo signaling pathway, acting as a tumor suppressor and regulator of cell proliferation and apoptosis. Its roles in cancer biology and normal cell functioning make it a significant focus in medical research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib, primarily a BCR-ABL inhibitor, has been shown to affect the Hippo pathway, possibly leading to altered MOB1A activity.

CX-4945

1009820-21-6sc-364475
sc-364475A
2 mg
50 mg
$183.00
$800.00
9
(2)

This inhibitor targets GSK-3β, which can intersect with Hippo signaling, potentially affecting MOB1A's role in this pathway.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

As a ROCK inhibitor, Y-27632 might indirectly modulate MOB1A activity via its effects on the actin cytoskeleton and Hippo pathway dynamics.

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

LPA can modulate the Hippo pathway, thus potentially influencing the activation state of MOB1A.

Stat3 Inhibitor VI, S3I-201

501919-59-1sc-204304
10 mg
$151.00
104
(1)

This inhibitor impacts STAT3, which may have cross-talk with the Hippo pathway, indirectly influencing MOB1A.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

As a CDK4/6 inhibitor, palbociclib could indirectly affect MOB1A activity through cell cycle regulatory pathways intersecting with Hippo.

AZD2014

1009298-59-2sc-364420
5 mg
$303.00
2
(0)

AZD8055, an mTOR inhibitor, might impact MOB1A activation by modulating upstream Hippo pathway components.

PP242

1092351-67-1sc-301606A
sc-301606
1 mg
5 mg
$57.00
$172.00
8
(1)

Similar to AZD8055, as an mTOR inhibitor, Torin 1 can influence Hippo pathway dynamics, potentially affecting MOB1A.